Nonneutralizing Functional Antibodies: a New “Old” Paradigm for HIV Vaccines
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nonneutralizing Functional Antibodies: a New “Old” Paradigm for HIV Vaccines
Authors
Keywords
-
Journal
Clinical and Vaccine Immunology
Volume 21, Issue 8, Pages 1023-1036
Publisher
American Society for Microbiology
Online
2014-06-12
DOI
10.1128/cvi.00230-14
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The promise of anti-ErbB3 monoclonals as new cancer therapeutics
- (2015) Luigi Aurisicchio et al. Oncotarget
- A Novel Role for Non-Neutralizing Antibodies against Nucleoprotein in Facilitating Resistance to Influenza Virus
- (2014) D. M. Carragher et al. JOURNAL OF IMMUNOLOGY
- HIV-1 Vaccine-Induced C1 and V2 Env-Specific Antibodies Synergize for Increased Antiviral Activities
- (2014) Justin Pollara et al. JOURNAL OF VIROLOGY
- Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection
- (2014) Susan Zolla-Pazner et al. PLoS One
- Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines
- (2014) A. W. Chung et al. Science Translational Medicine
- Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination
- (2014) N. L. Yates et al. Science Translational Medicine
- Epitope target structures of Fc-mediated effector function during HIV-1 acquisition
- (2014) George K. Lewis et al. Current Opinion in HIV and AIDS
- Anti-HIV IgA isotypes
- (2013) Jennifer D. Watkins et al. AIDS
- Broadly Neutralizing Antiviral Antibodies
- (2013) Davide Corti et al. Annual Review of Immunology
- Predictive markers of safety and immunogenicity of adjuvanted vaccines
- (2013) Beatris Mastelic et al. BIOLOGICALS
- Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys
- (2013) Dan H. Barouch et al. CELL
- Complex Correlates of Protection After Vaccination
- (2013) S. A. Plotkin CLINICAL INFECTIOUS DISEASES
- Fc Receptor-Mediated Immune Responses: New Tools But Increased Complexity in HIV Prevention
- (2013) Diego Vargas-Inchaustegui et al. CURRENT HIV RESEARCH
- Protective Antiviral Antibodies that Lack Neutralizing Activity: Precedents and Evolution of Concepts
- (2013) Alan Schmaljohn CURRENT HIV RESEARCH
- HIV-1 Variable Loop 2 and its Importance in HIV-1 Infection and Vaccine Development
- (2013) Mangala Rao et al. CURRENT HIV RESEARCH
- HIV-Specific Antibody Immunity Mediated Through NK Cells and Monocytes
- (2013) Marit Kramski et al. CURRENT HIV RESEARCH
- Non-neutralizing antibodies protect from chronic LCMV infection independently of activating FcγR or complement
- (2013) Kirsten Richter et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2
- (2013) Hua-Xin Liao et al. IMMUNITY
- Neutralizing antibodies to HIV-1 induced by immunization
- (2013) Laura E. McCoy et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Age-Associated Cross-reactive Antibody-Dependent Cellular Cytotoxicity Toward 2009 Pandemic Influenza A Virus Subtype H1N1
- (2013) Sinthujan Jegaskanda et al. JOURNAL OF INFECTIOUS DISEASES
- Infectious Virion Capture by HIV-1 gp120-Specific IgG from RV144 Vaccinees
- (2013) P. Liu et al. JOURNAL OF VIROLOGY
- The Canarypox Virus Vector ALVAC Induces Distinct Cytokine Responses Compared to the Vaccinia Virus-Based Vectors MVA and NYVAC in Rhesus Monkeys
- (2013) J. E. Teigler et al. JOURNAL OF VIROLOGY
- Molecular Evolution of the HIV-1 Thai Epidemic between the Time of RV144 Immunogen Selection to the Execution of the Vaccine Efficacy Trial
- (2013) G. H. Kijak et al. JOURNAL OF VIROLOGY
- Delayed Sequelae of Neonatal Respiratory Syncytial Virus Infection Are Dependent on Cells of the Innate Immune System
- (2013) J. A. Harker et al. JOURNAL OF VIROLOGY
- Identification of Dominant Antibody-Dependent Cell-Mediated Cytotoxicity Epitopes on the Hemagglutinin Antigen of Pandemic H1N1 Influenza Virus
- (2013) V. Srivastava et al. JOURNAL OF VIROLOGY
- Antibody-Dependent Cellular Cytotoxicity Is Associated with Control of Pandemic H1N1 Influenza Virus Infection of Macaques
- (2013) S. Jegaskanda et al. JOURNAL OF VIROLOGY
- Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques
- (2013) C Moog et al. Mucosal Immunology
- Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV
- (2013) Mario Roederer et al. NATURE
- Love the one you're with: the HIV, B cell and TFH cell triangle
- (2013) Shiv Pillai NATURE MEDICINE
- Inadequate T follicular cell help impairs B cell immunity during HIV infection
- (2013) Rafael A Cubas et al. NATURE MEDICINE
- Key roles of adjuvants in modern vaccines
- (2013) Steven G Reed et al. NATURE MEDICINE
- Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
- (2013) Scott M. Hammer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes
- (2013) Geert Leroux-Roels et al. PLoS One
- Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial
- (2013) Susan Zolla-Pazner et al. PLoS One
- Affinity-Purified Respiratory Syncytial Virus Antibodies from Intravenous Immunoglobulin Exert Potent Antibody-Dependent Cellular Cytotoxicity
- (2013) Nimesh Gupta et al. PLoS One
- Serum Cytokine Profiles Associated with Specific Adjuvants Used in a DNA Prime-Protein Boost Vaccination Strategy
- (2013) Rachel Buglione-Corbett et al. PLoS One
- Comparative Efficiency of HIV-1-Infected T Cell Killing by NK Cells, Monocytes and Neutrophils
- (2013) Adjoa Smalls-Mantey et al. PLoS One
- Epitope Mapping of Conformational V2-specific Anti-HIV Human Monoclonal Antibodies Reveals an Immunodominant Site in V2
- (2013) Luzia M. Mayr et al. PLoS One
- Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial
- (2013) Raphael Gottardo et al. PLoS One
- Differential Binding of IgG and IgA to Mucus of the Female Reproductive Tract
- (2013) Kelly M. Fahrbach et al. PLoS One
- DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge
- (2013) V. Patel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
- (2013) G. D. Tomaras et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Obstacles to ideal anti-HIV antibody-dependent cellular cytotoxicity responses
- (2013) Leia H. Wren et al. VACCINE
- HIV/SIV DNA vaccine combined with protein in a co-immunization protocol elicits highest humoral responses to envelope in mice and macaques
- (2013) Jinyao Li et al. VACCINE
- Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of Vaccines
- (2013) Wayne C. Koff et al. VACCINE
- Nanoparticle vaccines
- (2013) Liang Zhao et al. VACCINE
- Improvement of antibody responses by HIV envelope DNA and protein co-immunization
- (2013) Franco Pissani et al. VACCINE
- New paradigms for functional HIV-specific nonneutralizing antibodies
- (2013) Don Forthal et al. Current Opinion in HIV and AIDS
- HIV Transmission
- (2013) G. M. Shaw et al. Cold Spring Harbor Perspectives in Medicine
- Cooperativity Between CD8+ T Cells, Non-Neutralizing Antibodies, and Alveolar Macrophages Is Important for Heterosubtypic Influenza Virus Immunity
- (2013) Brian J. Laidlaw et al. PLoS Pathogens
- The Neonatal Fc Receptor (FcRn) Enhances Human Immunodeficiency Virus Type 1 (HIV-1) Transcytosis across Epithelial Cells
- (2013) Sandeep Gupta et al. PLoS Pathogens
- Physiochemical and Biochemical Factors Influencing the Pharmacokinetics of Antibody Therapeutics
- (2012) Daniela Bumbaca et al. AAPS Journal
- The Thai Phase III HIV Type 1 Vaccine Trial (RV144) Regimen Induces Antibodies That Target Conserved Regions Within the V2 Loop of gp120
- (2012) Nicos Karasavvas et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Comprehensive Investigation of Common Antibody-Dependent Cell-Mediated Cytotoxicity Antibody Epitopes of HIV-1 CRF01_AE gp120
- (2012) Silawun Ampol et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- High Titer and Avidity of Nonneutralizing Antibodies against Influenza Vaccine Antigen Are Associated with Severe Influenza
- (2012) Kelvin K. W. To et al. Clinical and Vaccine Immunology
- Nomenclature for Immune Correlates of Protection After Vaccination
- (2012) S. A. Plotkin et al. CLINICAL INFECTIOUS DISEASES
- Adjuvants for human vaccines
- (2012) Carl R Alving et al. CURRENT OPINION IN IMMUNOLOGY
- Non-neutralizing antibodies in prevention of HIV infection
- (2012) Harriet L. Robinson EXPERT OPINION ON BIOLOGICAL THERAPY
- CD4 T follicular helper cell dynamics during SIV infection
- (2012) Constantinos Petrovas et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunity to the Conserved Influenza Nucleoprotein Reduces Susceptibility to Secondary Bacterial Infections
- (2012) L. Haynes et al. JOURNAL OF IMMUNOLOGY
- The Thai Phase III Trial (RV144) Vaccine Regimen Induces T Cell Responses That Preferentially Target Epitopes within the V2 Region of HIV-1 Envelope
- (2012) M. S. de Souza et al. JOURNAL OF IMMUNOLOGY
- Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials
- (2012) D. C. Montefiori et al. JOURNAL OF INFECTIOUS DISEASES
- Early Appearance of Neutralizing Immunoglobulin G3 Antibodies Is Associated With Chikungunya Virus Clearance and Long-term Clinical Protection
- (2012) Yiu-Wing Kam et al. JOURNAL OF INFECTIOUS DISEASES
- Immunization of Macaques With Soluble HIV Type 1 and Influenza Virus Envelope Glycoproteins Results in a Similarly Rapid Contraction of Peripheral B-Cell Responses After Boosting
- (2012) Christopher Sundling, Paola Martinez, Martina Soldemo, Mats Spångberg, Karin Lövgren Bengtsson, Linda Stertman, Mattias N. E. Forsell et al. JOURNAL OF INFECTIOUS DISEASES
- Extended Evaluation of the Virologic, Immunologic, and Clinical Course of Volunteers Who Acquired HIV-1 Infection in a Phase III Vaccine Trial of ALVAC-HIV and AIDSVAX B/E
- (2012) Supachai Rerks-Ngarm et al. JOURNAL OF INFECTIOUS DISEASES
- Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family
- (2012) M. Bonsignori et al. JOURNAL OF VIROLOGY
- Antigenicity and Immunogenicity of RV144 Vaccine AIDSVAX Clade E Envelope Immunogen Is Enhanced by a gp120 N-Terminal Deletion
- (2012) S. Munir Alam et al. JOURNAL OF VIROLOGY
- A Short Segment of the HIV-1 gp120 V1/V2 Region Is a Major Determinant of Resistance to V1/V2 Neutralizing Antibodies
- (2012) N. A. Doria-Rose et al. JOURNAL OF VIROLOGY
- A Nonfucosylated Variant of the anti-HIV-1 Monoclonal Antibody b12 Has Enhanced Fc RIIIa-Mediated Antiviral Activity In Vitro but Does Not Improve Protection against Mucosal SHIV Challenge in Macaques
- (2012) B. Moldt et al. JOURNAL OF VIROLOGY
- Antibodies with High Avidity to the gp120 Envelope Protein in Protection from Simian Immunodeficiency Virus SIVmac251Acquisition in an Immunization Regimen That Mimics the RV-144 Thai Trial
- (2012) Poonam Pegu et al. JOURNAL OF VIROLOGY
- HIV-1 gp120 Vaccine Induces Affinity Maturation in both New and Persistent Antibody Clonal Lineages
- (2012) M. A. Moody et al. JOURNAL OF VIROLOGY
- Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144
- (2012) Merlin L Robb et al. LANCET INFECTIOUS DISEASES
- Human cervicovaginal mucus contains an activity that hinders HIV-1 movement
- (2012) S A Shukair et al. Mucosal Immunology
- Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
- (2012) Morgane Rolland et al. NATURE
- Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
- (2012) Dan H. Barouch et al. NATURE
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
- (2012) Barton F. Haynes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Monoclonal Antibodies to the V2 Domain of MN-rgp120: Fine Mapping of Epitopes and Inhibition of α4β7 Binding
- (2012) Gerald R. Nakamura et al. PLoS One
- Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction
- (2012) J. J. Moon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The mechanism of action of MF59 – An innately attractive adjuvant formulation
- (2012) D.T. O’Hagan et al. VACCINE
- Non healing leg ulcer infected withStenotrophomonas maltophilia: first reported case from India
- (2012) Falguni Nag et al. International Wound Journal
- HIV-Specific Antibodies Capable of ADCC Are Common in Breastmilk and Are Associated with Reduced Risk of Transmission in Women with High Viral Loads
- (2012) Jennifer Mabuka et al. PLoS Pathogens
- The broadly neutralizing HIV-1 IgG 2F5 elicits gp41-specific antibody-dependent cell cytotoxicity in a FcγRI-dependent manner
- (2011) Daniela Tudor et al. AIDS
- High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses
- (2011) Justin Pollara et al. CYTOMETRY PART A
- Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
- (2011) Nathalie Garçon et al. Expert Review of Vaccines
- HIV Vaccine efficacy trial: Glimmers of hope and the potential role of antibody-dependent cellular cytotoxicity
- (2011) Leia Wren et al. Human vaccines & immunotherapeutics
- Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges
- (2011) Morgane Bomsel et al. IMMUNITY
- Statistical Interpretation of the RV144 HIV Vaccine Efficacy Trial in Thailand: A Case Study for Statistical Issues in Efficacy Trials
- (2011) P. B. Gilbert et al. JOURNAL OF INFECTIOUS DISEASES
- An HIV-1 gp120 Envelope Human Monoclonal Antibody That Recognizes a C1 Conformational Epitope Mediates Potent Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity and Defines a Common ADCC Epitope in Human HIV-1 Serum
- (2011) G. Ferrari et al. JOURNAL OF VIROLOGY
- A Panel of IgG1 b12 Variants with Selectively Diminished or Enhanced Affinity for Fc Receptors To Define the Role of Effector Functions in Protection against HIV
- (2011) B. Moldt et al. JOURNAL OF VIROLOGY
- Altered distribution of mucosal NK cells during HIV infection
- (2011) M Sips et al. Mucosal Immunology
- Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
- (2011) Jason S. McLellan et al. NATURE
- Germinal center B and follicular helper T cells: siblings, cousins or just good friends?
- (2011) Stephen L Nutt et al. NATURE IMMUNOLOGY
- Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses
- (2011) James J. Moon et al. NATURE MATERIALS
- Moving ahead an HIV vaccine: To neutralize or not, a key HIV vaccine question
- (2011) Thomas J Hope NATURE MEDICINE
- Antibodies in oncology
- (2011) Vinochani Pillay et al. New Biotechnology
- Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody
- (2011) D. R. Burton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure
- (2011) A. W. Chung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
- (2011) X. Wu et al. SCIENCE
- Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
- (2011) J. F. Scheid et al. SCIENCE
- Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys
- (2011) N. L. Letvin et al. Science Translational Medicine
- HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX® B/E
- (2011) Robert Paris et al. VACCINE
- IgG Subclass Profiles in Infected HIV Type 1 Controllers and Chronic Progressors and in Uninfected Recipients of Env Vaccines
- (2010) Kaustuv Banerjee et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Correlates of Protection Induced by Vaccination
- (2010) S. A. Plotkin Clinical and Vaccine Immunology
- Follicular Helper T Cell Differentiation Requires Continuous Antigen Presentation that Is Independent of Unique B Cell Signaling
- (2010) Elissa K. Deenick et al. IMMUNITY
- Smallpox vaccines: targets of protective immunity
- (2010) Bernard Moss IMMUNOLOGICAL REVIEWS
- Mechanisms that determine plasma cell lifespan and the duration of humoral immunity
- (2010) Ian J. Amanna et al. IMMUNOLOGICAL REVIEWS
- Fc-Glycosylation Influences Fc Receptor Binding and Cell-Mediated Anti-HIV Activity of Monoclonal Antibody 2G12
- (2010) D. N. Forthal et al. JOURNAL OF IMMUNOLOGY
- Antibody to the E3 Glycoprotein Protects Mice against Lethal Venezuelan Equine Encephalitis Virus Infection
- (2010) M. D. Parker et al. JOURNAL OF VIROLOGY
- Multiple Vaccine-Elicited Nonneutralizing Antienvelope Antibody Activities Contribute to Protective Efficacy by Reducing both Acute and Chronic Viremia following Simian/Human Immunodeficiency Virus SHIV89.6P Challenge in Rhesus Macaques
- (2010) P. Xiao et al. JOURNAL OF VIROLOGY
- Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems
- (2010) Isabel Leroux-Roels et al. VACCINE
- Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms
- (2010) Devon J. Shedlock et al. VIROLOGY
- Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient
- (2010) John S Schieffelin et al. Virology Journal
- Contribution of Nonneutralizing Vaccine-Elicited Antibody Activities to Improved Protective Efficacy in Rhesus Macaques Immunized with Tat/Env Compared with Multigenic Vaccines
- (2009) R. H. Florese et al. JOURNAL OF IMMUNOLOGY
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection
- (2009) Y. Guan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The integrin 4 7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1
- (2009) C. Cicala et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Feline leukemia virus immunity induced by whole inactivated virus vaccination
- (2009) Andrea N. Torres et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Antibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination Strategies
- (2009) Vincent Holl et al. Viruses-Basel
- Correlation of Vaccine-Elicited Systemic and Mucosal Nonneutralizing Antibody Activities with Reduced Acute Viremia following Intrarectal Simian Immunodeficiency Virus SIVmac251 Challenge of Rhesus Macaques
- (2008) R. Hidajat et al. JOURNAL OF VIROLOGY
- HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
- (2008) M Juliana McElrath et al. LANCET
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
- (2008) Susan P Buchbinder et al. LANCET
- HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells
- (2008) James Arthos et al. NATURE IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started